EGFR, MSLN, MUC1, CEA, PD-L1, ROR1, HHLA2 (also referred to as B7H7), HER2, and various other target antigens are being studied for CAR-T therapy in lung cancer. Here, HHLA2 is linked to lung carcinoma.